| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2970888 | The Journal of Heart and Lung Transplantation | 2011 | 9 Pages |
Abstract
In the setting of allogeneic HCT, innate immune activation by LPS potentiates pulmonary GVHD through CXCR3-independent mechanisms. Clinical strategies focused on inhibition of CXCR3 may prove insufficient to ameliorate transplant-related lung disease.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Tereza MD, Christine V. MD, Kymberly M. PhD, Francine L. BS, Laurie D. MD, Dianhua MD, W. Michael PhD, Stavros MD, John A. MD, Paul W. MD, Scott M. MD, MHS,